U.S. markets close in 5 hours 32 minutes
  • S&P 500

    3,768.23
    -0.24 (-0.01%)
     
  • Dow 30

    31,009.98
    +85.84 (+0.28%)
     
  • Nasdaq

    12,606.23
    -117.24 (-0.92%)
     
  • Russell 2000

    2,139.42
    -7.50 (-0.35%)
     
  • Crude Oil

    65.93
    +2.10 (+3.29%)
     
  • Gold

    1,698.20
    -2.50 (-0.15%)
     
  • Silver

    25.26
    -0.20 (-0.79%)
     
  • EUR/USD

    1.1926
    -0.0053 (-0.44%)
     
  • 10-Yr Bond

    1.5730
    +0.0230 (+1.48%)
     
  • GBP/USD

    1.3821
    -0.0073 (-0.53%)
     
  • USD/JPY

    108.1220
    +0.1460 (+0.14%)
     
  • BTC-USD

    48,284.29
    -1,394.79 (-2.81%)
     
  • CMC Crypto 200

    965.17
    +22.00 (+2.33%)
     
  • FTSE 100

    6,692.48
    +41.60 (+0.63%)
     
  • Nikkei 225

    28,864.32
    -65.78 (-0.23%)
     

Vanda Pharmaceuticals to Announce First Quarter 2020 Financial Results on May 6, 2020

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Conference Call and Webcast to Follow

WASHINGTON, April 29, 2020 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2020 on Wednesday, May 6, 2020, after the market closes.

Vanda will host a conference call at 4:30 PM ET on Wednesday, May 6, 2020, during which management will discuss the first quarter 2020 financial results and other corporate activities. To participate in the conference call, please dial 1-866-688-9426 (domestic) or 1-409-216-0816 (international) and use passcode 2583625.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, May 6, 2020, beginning at 7:30 PM ET and will be accessible until Wednesday, May 13, 2020, at 7:30 PM ET. The replay call-in number is 1-855-859-2056 for domestic callers and 1-404-537-3406 for international callers. The passcode number is 2583625.

ABOUT VANDA PHARMACEUTICALS INC.:

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Corporate Contact:
AJ Jones II
Chief Corporate Affairs and Communications Officer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

SOURCE Vanda Pharmaceuticals Inc.

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2020-financial-results-on-may-6-2020-301049644.html

SOURCE Vanda Pharmaceuticals Inc.